TR
T. Rowe Price Investment Management, Inc. disclosed a 13.1% stake in CABA
T. Rowe Price Investment Management, Inc. reported owning 13.1% of Cabaletta Bio, Inc. (CABA) (28,138,417 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.